摘要
目的：观察胃炎1号方对脾虚气滞血瘀证慢性萎缩性胃炎患者的临床治疗效应。方法：40例Hp（＋）和40例（-）脾虚气滞血瘀证CAG患者分别随机均分为观察组和对照组，Hp（＋）组予PPI＋克拉霉素＋阿莫西林或PPI＋喹诺酮类＋呋喃唑酮抗Hp治疗，观察组予胃炎1号配方颗粒、对照组予胃复春治疗；Hp（-）观察组和对照组仅予胃炎1号配方颗粒和胃复春治疗，16周后观察疗效。结果：Hp（＋）观察组中医疗效、西医疗效和中医证侯积分均显著低于Hp（＋）对照组（P〈0.05）；Hp（-）观察组中医疗效、西医疗效和中医证侯积分均显著低于Hp（-）对照组（P〈0.05）。结论：胃炎1号可显著改善Hp（＋）和Hp（-）脾虚气滞血瘀证CAG患者的中医症状和体征，适用于脾虚气滞血瘀证CAG患者。
Objective：To observe the clinical efficacy of gastritis 1 on chronic atrophic gastritis of spleen deficiency and qi-stagnation and blood sta-sis. Methods：40 cases of Hp（＋） and 40 Hp（-） CAG patients with spleen deficiency and qi-stagnation and blood stasis were randomly divided into observation group and control group respectively, Hp（＋） were treated with PPI＋clarithromycin＋amoxicillin or PPI＋quinolone＋furazolidone, observation group adopted formula granule of gastritis 1, control group adopted Weifuchun, the observation and control group of Hp（-） were only treated with formula granule of gastritis 1 and Weifuchun, to observe the curative effect after 16 weeks. Results：Efficacy of Chinese and western medicine and syndrome integral of Hp（＋） observation group were all significantly better than that of Hp（＋） control group （P＆lt;0.05）;as well as Hp（-） observation group and Hp（-） control group （P＆lt;0.05）. Conclusion：Gastritis 1 can significantly improve the symptoms and signs of Chinese medi-cine of Hp（＋） and Hp（-） CAG of spleen deficiency and qi-stagnation and blood stasis, being suitable for CAG patients with spleen deficiency and qi-stagnation and blood stasis.
出处
《按摩与康复医学》
2014年第12期19-21,共3页
Chinese Manipulation and Rehabilitation Medicine
基金
基金项目：广东省中医药局课题项目,编号：20111121
广东省科技厅课题项目,编号：20128031800415
